nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CYP3A43—Dexamethasone—psoriatic arthritis	0.437	0.501	CbGbCtD
Ethosuximide—CYP3A7—Dexamethasone—psoriatic arthritis	0.0638	0.073	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0638	0.073	CbGbCtD
Ethosuximide—CYP2E1—Dexamethasone—psoriatic arthritis	0.0616	0.0705	CbGbCtD
Ethosuximide—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0493	0.0565	CbGbCtD
Ethosuximide—CYP3A5—Dexamethasone—psoriatic arthritis	0.0478	0.0548	CbGbCtD
Ethosuximide—CYP3A4—Triamcinolone—psoriatic arthritis	0.0374	0.0428	CbGbCtD
Ethosuximide—CYP3A4—Betamethasone—psoriatic arthritis	0.0321	0.0367	CbGbCtD
Ethosuximide—CYP3A4—Prednisolone—psoriatic arthritis	0.0316	0.0362	CbGbCtD
Ethosuximide—CYP3A4—Prednisone—psoriatic arthritis	0.0299	0.0342	CbGbCtD
Ethosuximide—CYP3A4—Dexamethasone—psoriatic arthritis	0.0187	0.0214	CbGbCtD
Ethosuximide—Aplastic anaemia—Auranofin—psoriatic arthritis	0.00398	0.0314	CcSEcCtD
Ethosuximide—Eosinophilia—Auranofin—psoriatic arthritis	0.00264	0.0208	CcSEcCtD
Ethosuximide—Pancytopenia—Auranofin—psoriatic arthritis	0.00253	0.0199	CcSEcCtD
Ethosuximide—Weight decreased—Auranofin—psoriatic arthritis	0.00241	0.019	CcSEcCtD
Ethosuximide—Hirsutism—Prednisolone—psoriatic arthritis	0.00233	0.0184	CcSEcCtD
Ethosuximide—Haematuria—Auranofin—psoriatic arthritis	0.00226	0.0178	CcSEcCtD
Ethosuximide—Systemic lupus erythematosus—Triamcinolone—psoriatic arthritis	0.00225	0.0177	CcSEcCtD
Ethosuximide—Agranulocytosis—Auranofin—psoriatic arthritis	0.00222	0.0175	CcSEcCtD
Ethosuximide—Hirsutism—Triamcinolone—psoriatic arthritis	0.00214	0.0169	CcSEcCtD
Ethosuximide—Hirsutism—Methylprednisolone—psoriatic arthritis	0.00214	0.0168	CcSEcCtD
Ethosuximide—Eye disorder—Auranofin—psoriatic arthritis	0.00199	0.0157	CcSEcCtD
Ethosuximide—Hirsutism—Betamethasone—psoriatic arthritis	0.00194	0.0153	CcSEcCtD
Ethosuximide—Hirsutism—Dexamethasone—psoriatic arthritis	0.00194	0.0153	CcSEcCtD
Ethosuximide—Suicidal ideation—Methylprednisolone—psoriatic arthritis	0.00177	0.014	CcSEcCtD
Ethosuximide—Hirsutism—Prednisone—psoriatic arthritis	0.00169	0.0133	CcSEcCtD
Ethosuximide—Leukopenia—Auranofin—psoriatic arthritis	0.00166	0.0131	CcSEcCtD
Ethosuximide—Suicidal ideation—Dexamethasone—psoriatic arthritis	0.00161	0.0127	CcSEcCtD
Ethosuximide—Suicidal ideation—Betamethasone—psoriatic arthritis	0.00161	0.0127	CcSEcCtD
Ethosuximide—Rash erythematous—Dexamethasone—psoriatic arthritis	0.00147	0.0116	CcSEcCtD
Ethosuximide—Rash erythematous—Betamethasone—psoriatic arthritis	0.00147	0.0116	CcSEcCtD
Ethosuximide—Anorexia—Auranofin—psoriatic arthritis	0.00144	0.0114	CcSEcCtD
Ethosuximide—Suicidal ideation—Prednisone—psoriatic arthritis	0.0014	0.0111	CcSEcCtD
Ethosuximide—Hiccups—Prednisolone—psoriatic arthritis	0.00135	0.0107	CcSEcCtD
Ethosuximide—Decreased appetite—Auranofin—psoriatic arthritis	0.00132	0.0104	CcSEcCtD
Ethosuximide—Hiccups—Triamcinolone—psoriatic arthritis	0.00124	0.00981	CcSEcCtD
Ethosuximide—Hiccups—Methylprednisolone—psoriatic arthritis	0.00124	0.00979	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00124	0.00976	CcSEcCtD
Ethosuximide—Urticaria—Auranofin—psoriatic arthritis	0.0012	0.00948	CcSEcCtD
Ethosuximide—Abdominal pain—Auranofin—psoriatic arthritis	0.0012	0.00944	CcSEcCtD
Ethosuximide—Euphoric mood—Prednisolone—psoriatic arthritis	0.00116	0.00917	CcSEcCtD
Ethosuximide—Hiccups—Betamethasone—psoriatic arthritis	0.00113	0.0089	CcSEcCtD
Ethosuximide—Hiccups—Dexamethasone—psoriatic arthritis	0.00113	0.0089	CcSEcCtD
Ethosuximide—Euphoric mood—Triamcinolone—psoriatic arthritis	0.00107	0.00843	CcSEcCtD
Ethosuximide—Euphoric mood—Methylprednisolone—psoriatic arthritis	0.00107	0.00841	CcSEcCtD
Ethosuximide—Diarrhoea—Auranofin—psoriatic arthritis	0.00104	0.00817	CcSEcCtD
Ethosuximide—Hiccups—Prednisone—psoriatic arthritis	0.000983	0.00775	CcSEcCtD
Ethosuximide—Euphoric mood—Dexamethasone—psoriatic arthritis	0.00097	0.00765	CcSEcCtD
Ethosuximide—Euphoric mood—Betamethasone—psoriatic arthritis	0.00097	0.00765	CcSEcCtD
Ethosuximide—Vomiting—Auranofin—psoriatic arthritis	0.000963	0.00759	CcSEcCtD
Ethosuximide—Rash—Auranofin—psoriatic arthritis	0.000955	0.00753	CcSEcCtD
Ethosuximide—Dermatitis—Auranofin—psoriatic arthritis	0.000954	0.00752	CcSEcCtD
Ethosuximide—Nausea—Auranofin—psoriatic arthritis	0.000899	0.00709	CcSEcCtD
Ethosuximide—Psychotic disorder—Methylprednisolone—psoriatic arthritis	0.00088	0.00694	CcSEcCtD
Ethosuximide—Irritability—Methylprednisolone—psoriatic arthritis	0.00086	0.00678	CcSEcCtD
Ethosuximide—Hyperkinesia—Prednisone—psoriatic arthritis	0.000858	0.00676	CcSEcCtD
Ethosuximide—Euphoric mood—Prednisone—psoriatic arthritis	0.000845	0.00666	CcSEcCtD
Ethosuximide—Lethargy—Betamethasone—psoriatic arthritis	0.000836	0.00659	CcSEcCtD
Ethosuximide—Lethargy—Dexamethasone—psoriatic arthritis	0.000836	0.00659	CcSEcCtD
Ethosuximide—Breast disorder—Methylprednisolone—psoriatic arthritis	0.000815	0.00642	CcSEcCtD
Ethosuximide—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.000801	0.00631	CcSEcCtD
Ethosuximide—Psychotic disorder—Betamethasone—psoriatic arthritis	0.000801	0.00631	CcSEcCtD
Ethosuximide—Irritability—Betamethasone—psoriatic arthritis	0.000782	0.00617	CcSEcCtD
Ethosuximide—Irritability—Dexamethasone—psoriatic arthritis	0.000782	0.00617	CcSEcCtD
Ethosuximide—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.000772	0.00608	CcSEcCtD
Ethosuximide—Lethargy—Prednisone—psoriatic arthritis	0.000728	0.00574	CcSEcCtD
Ethosuximide—Psychotic disorder—Prednisone—psoriatic arthritis	0.000697	0.0055	CcSEcCtD
Ethosuximide—Irritability—Prednisone—psoriatic arthritis	0.000681	0.00537	CcSEcCtD
Ethosuximide—Weight decreased—Dexamethasone—psoriatic arthritis	0.000641	0.00505	CcSEcCtD
Ethosuximide—Weight decreased—Betamethasone—psoriatic arthritis	0.000641	0.00505	CcSEcCtD
Ethosuximide—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000613	0.00483	CcSEcCtD
Ethosuximide—Lethargy—Methotrexate—psoriatic arthritis	0.000609	0.0048	CcSEcCtD
Ethosuximide—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000583	0.00459	CcSEcCtD
Ethosuximide—Irritability—Methotrexate—psoriatic arthritis	0.000569	0.00449	CcSEcCtD
Ethosuximide—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000563	0.00444	CcSEcCtD
Ethosuximide—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000562	0.00443	CcSEcCtD
Ethosuximide—Ataxia—Methotrexate—psoriatic arthritis	0.000561	0.00442	CcSEcCtD
Ethosuximide—Weight decreased—Prednisone—psoriatic arthritis	0.000558	0.0044	CcSEcCtD
Ethosuximide—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000546	0.00431	CcSEcCtD
Ethosuximide—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000543	0.00428	CcSEcCtD
Ethosuximide—Breast disorder—Methotrexate—psoriatic arthritis	0.000539	0.00425	CcSEcCtD
Ethosuximide—Eye disorder—Dexamethasone—psoriatic arthritis	0.00053	0.00418	CcSEcCtD
Ethosuximide—Eye disorder—Betamethasone—psoriatic arthritis	0.00053	0.00418	CcSEcCtD
Ethosuximide—Eosinophilia—Methotrexate—psoriatic arthritis	0.000511	0.00402	CcSEcCtD
Ethosuximide—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000494	0.0039	CcSEcCtD
Ethosuximide—Pancytopenia—Methotrexate—psoriatic arthritis	0.00049	0.00386	CcSEcCtD
Ethosuximide—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000485	0.00383	CcSEcCtD
Ethosuximide—Eye disorder—Prednisone—psoriatic arthritis	0.000461	0.00364	CcSEcCtD
Ethosuximide—Drowsiness—Methotrexate—psoriatic arthritis	0.00046	0.00362	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000459	0.00362	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000456	0.00359	CcSEcCtD
Ethosuximide—Immune system disorder—Prednisone—psoriatic arthritis	0.000446	0.00352	CcSEcCtD
Ethosuximide—Haematuria—Methotrexate—psoriatic arthritis	0.000438	0.00346	CcSEcCtD
Ethosuximide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000434	0.00342	CcSEcCtD
Ethosuximide—Mental disorder—Prednisone—psoriatic arthritis	0.000433	0.00341	CcSEcCtD
Ethosuximide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00043	0.00339	CcSEcCtD
Ethosuximide—Malnutrition—Prednisone—psoriatic arthritis	0.00043	0.00339	CcSEcCtD
Ethosuximide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000429	0.00338	CcSEcCtD
Ethosuximide—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000408	0.00321	CcSEcCtD
Ethosuximide—Urethral disorder—Methotrexate—psoriatic arthritis	0.000405	0.00319	CcSEcCtD
Ethosuximide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000395	0.00311	CcSEcCtD
Ethosuximide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000395	0.00311	CcSEcCtD
Ethosuximide—Agitation—Prednisone—psoriatic arthritis	0.000395	0.00311	CcSEcCtD
Ethosuximide—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00039	0.00308	CcSEcCtD
Ethosuximide—Eye disorder—Methotrexate—psoriatic arthritis	0.000386	0.00304	CcSEcCtD
Ethosuximide—Anorexia—Dexamethasone—psoriatic arthritis	0.000384	0.00303	CcSEcCtD
Ethosuximide—Anorexia—Betamethasone—psoriatic arthritis	0.000384	0.00303	CcSEcCtD
Ethosuximide—Urticaria—Prednisolone—psoriatic arthritis	0.000384	0.00302	CcSEcCtD
Ethosuximide—Fatigue—Triamcinolone—psoriatic arthritis	0.000383	0.00302	CcSEcCtD
Ethosuximide—Fatigue—Methylprednisolone—psoriatic arthritis	0.000382	0.00301	CcSEcCtD
Ethosuximide—Immune system disorder—Methotrexate—psoriatic arthritis	0.000373	0.00294	CcSEcCtD
Ethosuximide—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000372	0.00293	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000363	0.00287	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000362	0.00286	CcSEcCtD
Ethosuximide—Mental disorder—Methotrexate—psoriatic arthritis	0.000362	0.00285	CcSEcCtD
Ethosuximide—Malnutrition—Methotrexate—psoriatic arthritis	0.000359	0.00283	CcSEcCtD
Ethosuximide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000356	0.0028	CcSEcCtD
Ethosuximide—Urticaria—Triamcinolone—psoriatic arthritis	0.000353	0.00278	CcSEcCtD
Ethosuximide—Urticaria—Methylprednisolone—psoriatic arthritis	0.000352	0.00277	CcSEcCtD
Ethosuximide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00035	0.00276	CcSEcCtD
Ethosuximide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00035	0.00276	CcSEcCtD
Ethosuximide—Decreased appetite—Betamethasone—psoriatic arthritis	0.00035	0.00276	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000348	0.00274	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000348	0.00274	CcSEcCtD
Ethosuximide—Fatigue—Dexamethasone—psoriatic arthritis	0.000347	0.00274	CcSEcCtD
Ethosuximide—Fatigue—Betamethasone—psoriatic arthritis	0.000347	0.00274	CcSEcCtD
Ethosuximide—Nervous system disorder—Prednisone—psoriatic arthritis	0.000344	0.00271	CcSEcCtD
Ethosuximide—Skin disorder—Prednisone—psoriatic arthritis	0.000341	0.00269	CcSEcCtD
Ethosuximide—Anorexia—Prednisone—psoriatic arthritis	0.000334	0.00264	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000329	0.0026	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000329	0.0026	CcSEcCtD
Ethosuximide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000327	0.00258	CcSEcCtD
Ethosuximide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000326	0.00257	CcSEcCtD
Ethosuximide—Leukopenia—Methotrexate—psoriatic arthritis	0.000322	0.00254	CcSEcCtD
Ethosuximide—Urticaria—Dexamethasone—psoriatic arthritis	0.00032	0.00252	CcSEcCtD
Ethosuximide—Urticaria—Betamethasone—psoriatic arthritis	0.00032	0.00252	CcSEcCtD
Ethosuximide—Dizziness—Prednisolone—psoriatic arthritis	0.000319	0.00252	CcSEcCtD
Ethosuximide—Asthenia—Triamcinolone—psoriatic arthritis	0.000319	0.00251	CcSEcCtD
Ethosuximide—Abdominal pain—Betamethasone—psoriatic arthritis	0.000318	0.00251	CcSEcCtD
Ethosuximide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000318	0.00251	CcSEcCtD
Ethosuximide—Asthenia—Methylprednisolone—psoriatic arthritis	0.000318	0.00251	CcSEcCtD
Ethosuximide—Decreased appetite—Prednisone—psoriatic arthritis	0.000305	0.0024	CcSEcCtD
Ethosuximide—Rash—Prednisolone—psoriatic arthritis	0.000304	0.0024	CcSEcCtD
Ethosuximide—Dermatitis—Prednisolone—psoriatic arthritis	0.000304	0.0024	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000304	0.00239	CcSEcCtD
Ethosuximide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000303	0.00239	CcSEcCtD
Ethosuximide—Fatigue—Prednisone—psoriatic arthritis	0.000302	0.00238	CcSEcCtD
Ethosuximide—Headache—Prednisolone—psoriatic arthritis	0.000302	0.00238	CcSEcCtD
Ethosuximide—Dizziness—Triamcinolone—psoriatic arthritis	0.000294	0.00231	CcSEcCtD
Ethosuximide—Dizziness—Methylprednisolone—psoriatic arthritis	0.000293	0.00231	CcSEcCtD
Ethosuximide—Asthenia—Dexamethasone—psoriatic arthritis	0.000289	0.00228	CcSEcCtD
Ethosuximide—Asthenia—Betamethasone—psoriatic arthritis	0.000289	0.00228	CcSEcCtD
Ethosuximide—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000288	0.00227	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000287	0.00226	CcSEcCtD
Ethosuximide—Nausea—Prednisolone—psoriatic arthritis	0.000287	0.00226	CcSEcCtD
Ethosuximide—Skin disorder—Methotrexate—psoriatic arthritis	0.000285	0.00225	CcSEcCtD
Ethosuximide—Vomiting—Triamcinolone—psoriatic arthritis	0.000282	0.00223	CcSEcCtD
Ethosuximide—Vomiting—Methylprednisolone—psoriatic arthritis	0.000282	0.00222	CcSEcCtD
Ethosuximide—Rash—Triamcinolone—psoriatic arthritis	0.00028	0.00221	CcSEcCtD
Ethosuximide—Dermatitis—Triamcinolone—psoriatic arthritis	0.00028	0.0022	CcSEcCtD
Ethosuximide—Anorexia—Methotrexate—psoriatic arthritis	0.000279	0.0022	CcSEcCtD
Ethosuximide—Rash—Methylprednisolone—psoriatic arthritis	0.000279	0.0022	CcSEcCtD
Ethosuximide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000279	0.0022	CcSEcCtD
Ethosuximide—Urticaria—Prednisone—psoriatic arthritis	0.000279	0.0022	CcSEcCtD
Ethosuximide—Headache—Triamcinolone—psoriatic arthritis	0.000278	0.00219	CcSEcCtD
Ethosuximide—Headache—Methylprednisolone—psoriatic arthritis	0.000278	0.00219	CcSEcCtD
Ethosuximide—Abdominal pain—Prednisone—psoriatic arthritis	0.000277	0.00219	CcSEcCtD
Ethosuximide—Diarrhoea—Betamethasone—psoriatic arthritis	0.000276	0.00217	CcSEcCtD
Ethosuximide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000276	0.00217	CcSEcCtD
Ethosuximide—Dizziness—Dexamethasone—psoriatic arthritis	0.000266	0.0021	CcSEcCtD
Ethosuximide—Dizziness—Betamethasone—psoriatic arthritis	0.000266	0.0021	CcSEcCtD
Ethosuximide—Nausea—Triamcinolone—psoriatic arthritis	0.000264	0.00208	CcSEcCtD
Ethosuximide—Nausea—Methylprednisolone—psoriatic arthritis	0.000263	0.00207	CcSEcCtD
Ethosuximide—Somnolence—Methotrexate—psoriatic arthritis	0.000261	0.00205	CcSEcCtD
Ethosuximide—Hypersensitivity—Prednisone—psoriatic arthritis	0.000258	0.00204	CcSEcCtD
Ethosuximide—Vomiting—Dexamethasone—psoriatic arthritis	0.000256	0.00202	CcSEcCtD
Ethosuximide—Vomiting—Betamethasone—psoriatic arthritis	0.000256	0.00202	CcSEcCtD
Ethosuximide—Decreased appetite—Methotrexate—psoriatic arthritis	0.000255	0.00201	CcSEcCtD
Ethosuximide—Rash—Dexamethasone—psoriatic arthritis	0.000254	0.002	CcSEcCtD
Ethosuximide—Rash—Betamethasone—psoriatic arthritis	0.000254	0.002	CcSEcCtD
Ethosuximide—Dermatitis—Betamethasone—psoriatic arthritis	0.000254	0.002	CcSEcCtD
Ethosuximide—Dermatitis—Dexamethasone—psoriatic arthritis	0.000254	0.002	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000253	0.002	CcSEcCtD
Ethosuximide—Fatigue—Methotrexate—psoriatic arthritis	0.000253	0.00199	CcSEcCtD
Ethosuximide—Headache—Betamethasone—psoriatic arthritis	0.000252	0.00199	CcSEcCtD
Ethosuximide—Headache—Dexamethasone—psoriatic arthritis	0.000252	0.00199	CcSEcCtD
Ethosuximide—Asthenia—Prednisone—psoriatic arthritis	0.000252	0.00198	CcSEcCtD
Ethosuximide—Diarrhoea—Prednisone—psoriatic arthritis	0.00024	0.00189	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00024	0.00189	CcSEcCtD
Ethosuximide—Nausea—Dexamethasone—psoriatic arthritis	0.000239	0.00189	CcSEcCtD
Ethosuximide—Nausea—Betamethasone—psoriatic arthritis	0.000239	0.00189	CcSEcCtD
Ethosuximide—Urticaria—Methotrexate—psoriatic arthritis	0.000233	0.00184	CcSEcCtD
Ethosuximide—Dizziness—Prednisone—psoriatic arthritis	0.000232	0.00183	CcSEcCtD
Ethosuximide—Abdominal pain—Methotrexate—psoriatic arthritis	0.000232	0.00183	CcSEcCtD
Ethosuximide—Vomiting—Prednisone—psoriatic arthritis	0.000223	0.00176	CcSEcCtD
Ethosuximide—Rash—Prednisone—psoriatic arthritis	0.000221	0.00174	CcSEcCtD
Ethosuximide—Dermatitis—Prednisone—psoriatic arthritis	0.000221	0.00174	CcSEcCtD
Ethosuximide—Headache—Prednisone—psoriatic arthritis	0.00022	0.00173	CcSEcCtD
Ethosuximide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000216	0.0017	CcSEcCtD
Ethosuximide—Asthenia—Methotrexate—psoriatic arthritis	0.00021	0.00166	CcSEcCtD
Ethosuximide—Nausea—Prednisone—psoriatic arthritis	0.000208	0.00164	CcSEcCtD
Ethosuximide—Diarrhoea—Methotrexate—psoriatic arthritis	0.000201	0.00158	CcSEcCtD
Ethosuximide—Dizziness—Methotrexate—psoriatic arthritis	0.000194	0.00153	CcSEcCtD
Ethosuximide—Vomiting—Methotrexate—psoriatic arthritis	0.000186	0.00147	CcSEcCtD
Ethosuximide—Rash—Methotrexate—psoriatic arthritis	0.000185	0.00146	CcSEcCtD
Ethosuximide—Dermatitis—Methotrexate—psoriatic arthritis	0.000185	0.00146	CcSEcCtD
Ethosuximide—Headache—Methotrexate—psoriatic arthritis	0.000184	0.00145	CcSEcCtD
Ethosuximide—Nausea—Methotrexate—psoriatic arthritis	0.000174	0.00137	CcSEcCtD
